NCT04507126: A reported trial by Massachusetts General Hospital
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT04507126 |
|---|---|
| Title | Effects of Bacillus Calmette-Guérin (BCG) Immunization on Cerebrospinal Fluid (CSF) and Blood-Based Biomarkers in Older Adults: A Pilot |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 1, 2021 |
| Completion date | April 27, 2022 |
| Required reporting date | April 27, 2023, midnight |
| Actual reporting date | April 2, 2023 |
| Date last checked at ClinicalTrials.gov | Aug. 26, 2025 |
| Days late | None |